No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Phase I Design market within the context of Clinical Trials is a specialized segment of the pharmaceutical industry. It involves the development of new drugs and treatments, and the testing of these products in clinical trials. The goal of Phase I Design is to assess the safety and efficacy of a drug or treatment before it is approved for use in humans. This process typically involves a series of clinical trials, which are conducted in a controlled environment and monitored by medical professionals. The results of these trials are then used to determine whether the drug or treatment is safe and effective for use in humans.
Companies in the Phase I Design market include Parexel, ICON, Syneos Health, PPD, and Quintiles. Show Less Read more
